A detailed history of Principal Financial Group Inc transactions in Procept Bio Robotics Corp stock. As of the latest transaction made, Principal Financial Group Inc holds 162,713 shares of PRCT stock, worth $11.8 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
162,713
Holding current value
$11.8 Million
% of portfolio
0.01%

Shares

11 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2024

Jan 31, 2025

BUY
$67.27 - $99.45 $10.9 Million - $16.2 Million
162,713 New
162,713 $13.1 Million
Q3 2024

Oct 31, 2024

BUY
$56.31 - $84.99 $2.87 Million - $4.34 Million
51,030 Added 290.16%
68,617 $5.5 Million
Q2 2024

Jul 29, 2024

SELL
$45.73 - $69.19 $155,299 - $234,969
-3,396 Reduced 16.18%
17,587 $1.07 Million
Q1 2024

Apr 29, 2024

BUY
$40.38 - $50.75 $419,750 - $527,546
10,395 Added 98.18%
20,983 $1.04 Million
Q4 2023

Feb 07, 2024

BUY
$24.89 - $43.41 $14,137 - $24,656
568 Added 5.67%
10,588 $443,000
Q3 2023

Nov 02, 2023

SELL
$30.02 - $38.81 $7,414 - $9,586
-247 Reduced 2.41%
10,020 $328,000
Q2 2023

Aug 07, 2023

BUY
$26.7 - $37.02 $25,311 - $35,094
948 Added 10.17%
10,267 $362,000
Q1 2023

May 09, 2023

SELL
$26.64 - $39.74 $652,973 - $974,067
-24,511 Reduced 72.45%
9,319 $264,000
Q4 2022

Feb 09, 2023

BUY
$38.78 - $46.78 $972,330 - $1.17 Million
25,073 Added 286.32%
33,830 $1.41 Million
Q3 2022

Nov 09, 2022

SELL
$30.9 - $50.65 $432,939 - $709,657
-14,011 Reduced 61.54%
8,757 $364,000
Q2 2022

Aug 10, 2022

BUY
$29.23 - $44.45 $665,508 - $1.01 Million
22,768 New
22,768 $744,000

Others Institutions Holding PRCT

About PROCEPT BioRobotics Corp


  • Ticker PRCT
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 44,592,300
  • Market Cap $3.23B
  • Description
  • PROCEPT BioRobotics Corporation, a surgical robotics company, develops transformative solutions in urology. It develops, manufactures, and sells AquaBeam Robotic System, an image-guided, surgical robotic system for use in minimally-invasive urologic surgery with a focus on treating benign prostatic hyperplasia (BPH). The company also designs Aqu...
More about PRCT
Track This Portfolio

Track Principal Financial Group Inc Portfolio

Follow Principal Financial Group Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Principal Financial Group Inc, based on Form 13F filings with the SEC.

News

Stay updated on Principal Financial Group Inc with notifications on news.